A groundbreaking study led by Professor Takuya Takahashi reveals a significant connection between elevated AMPA receptor density and cognitive symptoms in Long COVID patients. This finding could lead to new diagnostic and treatment strategies.
A team of scientists at Johns Hopkins Medicine has unveiled how glutamate activates brain receptors using advanced cryo-EM imaging, paving the way for novel treatments for epilepsy and other neurological conditions.
